Article ISI SCOPUS
PLOS ONE  (2015)

Cost Effectiveness of Daclatasvir/Asunaprevir Versus Peginterferon/Ribavirin and Protease Inhibitors for the Treatment of Hepatitis c Genotype 1b Naive Patients in Chile

Vargas, CL; Espinoza, MA; Giglio, A; Soza, A

Más información

Título según WOS: Cost Effectiveness of Daclatasvir/Asunaprevir Versus Peginterferon/Ribavirin and Protease Inhibitors for the Treatment of Hepatitis c Genotype 1b Naive Patients in Chile
Título según SCOPUS: Cost effectiveness of daclatasvir/asunaprevir versus peginterferon/ribavirin and protease inhibitors for the treatment of hepatitis c genotype 1b Naïve patients in Chile
Título de la Revista: PLOS ONE
Volumen: 10
Número: 11
Editorial: PUBLIC LIBRARY SCIENCE
Fecha de publicación: 2015
Idioma: English
DOI:

10.1371/journal.pone.0141660
Notas: ISI, SCOPUS